最新发布

Can dark fermentation reshape the natural astaxanthin market?

Natural astaxanthin—a potent antioxidant that sells for thousands of dollars per kilo—has historically been produced by …

🎥 Can editing the ‘dark genome’ make crops more heat tolerant?

[Disclosure: AgFunderNews’ parent company AgFunder is an investor in Plantik Biosciences.] Can editing the so-called “da…

Pharmanovia licenses China-approved PARP drug for up to €423.5M

Why it matters: The agreement takes IMPACT’s first approved medicine beyond China and gives Pharmanovia a near-market ovarian cancer asset that is already under European regulatory review.

2026年第8批749个农药拟登记:苯丙草酮首登(EX)、山东新和成精草铵盐原药将取证、砜吡草唑扩作大豆田

世界农化网中文网报道:2026年7月30日,农业农村部农药检定所公示2026年第8批拟批准登记农药产品,其中,749个新申请登记的农药产品拟批准登记。

Relation deepens GSK alliance with $110M deal

Why it matters: The deal moves Relation’s relationship with GSK beyond the discovery of targets in specific diseases and into the infrastructure underlying its broader AI platform. The new funding will help Relation generate the large, experimentally produced datasets needed to train MORGAN, its newly unveiled model of cellular biology.

全国农业植物检疫版图仍在净扩张!水稻细菌性条斑病菌、红火蚁、柑橘黄龙病菌 ~

世界农化网中文网报道:2026年7月27日,农业农村部种植业管理司发布最新版《全国农业植物检疫性有害生物分布行政区名录》。这份截至2026年6月30日的名录覆盖32种检疫性有害生物,合计分布记录3358个县次。

Sanofi axes two more inflammatory-disease drugs

Why it matters: The decisions remove two externally sourced drugs from Sanofi’s immunology pipeline, days after the French pharmaceutical group also abandoned amlitelimab, the eczema antibody obtained through its $1.1 billion acquisition of UK biotech Kymab. The decision was announced as part of Sanofi’s Q2 2026 financial results.

CHMP backs first CETP inhibitor after two decades of failure

Why it matters: A new class of cholesterol drug is finally close to reaching the European market. Obicetrapib will be the first CETP inhibitor to ever gain a regulatory nod and to do so on this side of the Atlantic first.

Sipcam Nichino在巴西展出丙硫菌唑新品杀菌剂,聚焦大田作物病害

世界农化网中文网报道:近日,Sipcam Nichino Brasil借Coopercitrus Expo 2026展会之机,提前披露了其新型内吸性杀菌剂Cortina® Gold(丙硫菌唑+百菌清),该产品瞄准大豆、玉米和棉花等大田作物的主要病害防控。

GSK announces plan to axe UK Stevenage R&D hub, moving to Cambridge

Why it matters: It’s a major strategic move by new CEO Luke Miels, who took over on 1st January from Emma Walmsley. GSK said it will vacate its R&D site at Stevenage, Hertfordshire, with a phased move for employees by 2029. Alongside the move to Cambridge, GSK will upgrade its existing R&D laboratories at Ware in Hertfordshire and move some employees there.